BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15131005)

  • 1. Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component.
    Neri Serneri GG; Boddi M; Modesti PA; Coppo M; Cecioni I; Toscano T; Papa ML; Bandinelli M; Lisi GF; Chiavarelli M
    Circ Res; 2004 Jun; 94(12):1630-7. PubMed ID: 15131005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomediated and ischemia-independent inflammation of coronary microvessels in unstable angina.
    Neri Serneri GG; Boddi M; Modesti PA; Cecioni I; Coppo M; Papa ML; Toscano T; Marullo A; Chiavarelli M
    Circ Res; 2003 Jun; 92(12):1359-66. PubMed ID: 12775581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac angiotensin is upregulated in the hearts of unstable angina patients.
    Luft FC
    Circ Res; 2004 Jun; 94(12):1530-2. PubMed ID: 15217917
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of cardiac renin-angiotensin system in unstable angina.
    Neri Serneri GG; Boddi M; Poggesi L; Simonetti I; Coppo M; Papa ML; Lisi GF; Maccherini M; Becherini R; Boncompagni A; Toscano T; Modesti PA
    J Am Coll Cardiol; 2001 Jul; 38(1):49-55. PubMed ID: 11451295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure.
    Batlle M; Roig E; Perez-Villa F; Lario S; Cejudo-Martin P; García-Pras E; Ortiz J; Roqué M; Orús J; Rigol M; Heras M; Ramírez J; Jimenez W
    J Heart Lung Transplant; 2006 Sep; 25(9):1117-25. PubMed ID: 16962475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
    Esnault VL; Ekhlas A; Nguyen JM; Moranne O
    Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin-converting enzyme inhibitor versus valsartan on cellular signaling events in heart transplant.
    White M; Ross H; Levesque S; Whittom L; Pelletier GB; Racine N; Meloche S; Voisin L
    Ann Pharmacother; 2009 May; 43(5):831-9. PubMed ID: 19417110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker.
    Zhu S; Liu Y; Wang L; Meng QH
    Nephrol Dial Transplant; 2008 Sep; 23(9):2841-6. PubMed ID: 18390891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
    Sandmann S; Li J; Fritzenkötter C; Spormann J; Tiede K; Fischer JW; Unger T
    Blood Press; 2006; 15(2):116-28. PubMed ID: 16754275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II upregulates renin-angiotensin system in human isolated T lymphocytes.
    Coppo M; Boddi M; Bandinelli M; Degl'innocenti D; Ramazzotti M; Marra F; Galastri S; Abbate R; Gensini GF; Poggesi L
    Regul Pept; 2008 Nov; 151(1-3):1-6. PubMed ID: 18723052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.
    Suşan M; Petrescu L; Riviş AI; Suşan RM; Burghină D; Dan R; Cozma D; Drăgulescu SI
    Rom J Intern Med; 2005; 43(3-4):187-98. PubMed ID: 16812979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
    J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On angiotensin II receptor distribution after myocardial infarction in dogs].
    Qu XF; Li JJ; Xi Y; Shen JX; Xiu CH; Yue L; Wang GZ; Huang YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):358-62. PubMed ID: 19791474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade.
    Feng TC; Ying WY; Hua RJ; Ji YY; de Gasparo M
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):19-24. PubMed ID: 11881060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valsartan versus ACE inhibition after bare metal stent implantation--results of the VALVACE trial.
    Peters S; Trümmel M; Meyners W; Koehler B; Westermann K
    Int J Cardiol; 2005 Feb; 98(2):331-5. PubMed ID: 15686787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of angiotensin II on dihydrofolate reductase, GTP-cyclohydrolase 1 and nitric oxide synthase expressions in renal ischemia-reperfusion.
    Seujange Y; Eiam-Ong S; Tirawatnapong T; Eiam-Ong S
    Am J Nephrol; 2008; 28(4):692-700. PubMed ID: 18408363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for angiotensin II receptor blocker therapy in chronic heart failure.
    Cohn JN
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S38-40. PubMed ID: 17199220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.